| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 60 |
| 1 | INFLIXIMAB | 56 |
| 2 | METHOTREXATE | 50 |
| 3 | ADALIMUMAB | 38 |
| 4 | PREDNISOLONE | 27 |
| 5 | PREDNISOLONE ORAL | 27 |
| 6 | PREDNISOLONE ORAL SOLUTION | 27 |
| 7 | ADALIMUMAB-AATY | 26 |
| 8 | ADALIMUMAB-ADAZ | 26 |
| 9 | ADALIMUMAB-FKJP | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILTEFOSINE | 5 | 0.0129 |
| 1 | RIFABUTIN | 8 | 0.0029 |
| 2 | DEFLAZACORT | 7 | 0.0027 |
| 3 | AMPHOTERICIN B LIPOSOME | 5 | 0.0021 |
| 4 | AMPHOTERICIN B | 22 | 0.0017 |
| 5 | DARUNAVIR 600 MG | 10 | 0.0016 |
| 6 | ATOVAQUONE | 8 | 0.0010 |
| 7 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 8 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 9 | DARUNAVIR | 11 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 5 | 0.0129 |
| 1 | Rifamycin Antimycobacterial [EPC] | 8 | 0.0023 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 27 | 0.0021 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 4 | Antimalarial [EPC] | 8 | 0.0008 |
| 5 | Antiprotozoal [EPC] | 8 | 0.0008 |
| 6 | Polyene Antifungal [EPC] | 27 | 0.0007 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 9 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |